search query: @indexterm BIO-TECHNOLOGY / total: 177
references: 21-30 / 177
« previous page | next page »
 titleyearauthor
21.
Canada's stem cell corporation: Aggregate concerns and the question of public trust
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.73-84
 2008 Herder, M.
Brian, J. D.
22.
Sowing the seeds of reason in the field of the terminator debate
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.65-72
 2008 Bustos, K.
23.
Social exclusion and transgenic technology: The case of Brazilian agriculture
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 45-63
 2008 Hall, J.
Matos, S.
Langford, C. L.
24.
Challenges for corporate ethics in marketing genetic tests
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 33-44
 2008 Williams-Jones, B.
Ozdemir, V.
25.
The ethical challenges of direct-to-consumer genetic testing
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.17-31
 2008 Berg, C.
Fryer-Edwards, K.
26.
Technology, cooperation and stock market value: an event study of new partnership announcements in the biotechnology and pharmaceutical industries
Economics of innovation and new technology
2007 : JAN-MAR, VOL. 16:1-2, p. 31-49
 2007 Campart, S.
Pfister, E.
27.
Branching out
Business Strategy Review
2007 : VOL. 18:2, p. 19-23
 2007 Peters, G.
28.
Developing social responsibility: Biotechnology and the case of DuPont in Brazil
Journal of Business Ethics
2007 : JUN (II), VOL. 73:1, p. 103-118
 2007 Griesse, M. A.
29.
Critical success factors for firms in the genetically modified foods industry: A managerial perspective
Journal of Asia-Pacific Business
2007 : VOL. 8:2, p. 5-23
 2007 D'Souza, C. (et al.)
30.
Rigidity, exploratory patience, and the ecological resilience of organizations
Scandinavian Journal of Management
2007 : JUN, VOL. 23:2, p. 206-213
 2007 Välikangas, L.
« previous page | next page »
SCIMA